enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. European Commission–AstraZeneca COVID-19 vaccine dispute

    en.wikipedia.org/wiki/European_Commission...

    A packet of AstraZeneca COVID-19 vaccine vials. A dispute broke out in January 2021 between the European Commission and the pharmaceutical company AstraZeneca AB about the provision of COVID-19 vaccines during the COVID-19 pandemic, [1] and, in February, spilled out into a dispute over Article 16 of the Northern Ireland Protocol.

  3. History of COVID-19 vaccine development - Wikipedia

    en.wikipedia.org/wiki/History_of_COVID-19...

    All RMPs for COVID‑19 vaccines will be published on the EMA's website. [136] The EMA published guidance for developers of potential COVID‑19 vaccines on the clinical evidence to include in marketing authorization applications. [137] In November 2020, the CHMP started a rolling review of the Moderna vaccine for COVID‑19 known as mRNA-1273 ...

  4. CureVac - Wikipedia

    en.wikipedia.org/wiki/CureVac

    As of December 2020, CVnCoV was in a Phase III clinical trial of 36,500 participants. [34] [35] On 12 February 2021, CureVac announced the initiation of a rolling submission with the European Medicines Agency (EMA) for their vaccine candidate, a time-optimized process for the review of all data necessary for potential market authorization. [37]

  5. COVID-19 vaccine - Wikipedia

    en.wikipedia.org/wiki/COVID-19_vaccine

    How COVID‑19 vaccines work. The video shows the process of vaccination, from injection with RNA or viral vector vaccines, to uptake and translation, and on to immune system stimulation and effect. Part of a series on the COVID-19 pandemic Scientifically accurate atomic model of the external structure of SARS-CoV-2. Each "ball" is an atom. COVID-19 (disease) SARS-CoV-2 (virus) Cases Deaths ...

  6. CureVac COVID-19 vaccine - Wikipedia

    en.wikipedia.org/wiki/CureVac_COVID-19_vaccine

    The CureVac COVID-19 vaccine (abbreviated CVnCoV) was a COVID-19 vaccine candidate developed by CureVac N.V. and the Coalition for Epidemic Preparedness Innovations (CEPI). [3] The vaccine showed inadequate results in its Phase III trials with only 47% efficacy. [ 4 ]

  7. NYC comptroller asks feds to decide whether Cuomo violated ...

    www.aol.com/nyc-comptroller-asks-feds-decide...

    A declared mayoral candidate, city Comptroller Brad Lander, is asking US health officials to determine whether ex-Gov. Andrew Cuomo's controversial March 25, 2020 order requiring nursing homes to ...

  8. List of COVID-19 vaccine authorizations - Wikipedia

    en.wikipedia.org/wiki/List_of_COVID-19_vaccine...

    National regulatory authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines.. Ten vaccines have been approved for emergency or full use by at least one stringent regulatory authority recognized by the World Health Organization (WHO): Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia, and Sanofi ...

  9. US Supreme Court rejects tobacco firms' appeal over graphic ...

    www.aol.com/news/us-supreme-court-sidesteps...

    The rule was adopted by the agency in 2020 during Donald Trump's first presidential administration. The FDA required that warnings about the risks of smoking occupy the top 50% of cigarette packs ...